CSS »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CSS

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CSS from 13F filings

Historical chart of CSS investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.4M 9.0M 0.93

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Noble Corp Ord Shs A (NE)
Ark Etf Tr Innovation Etf Call Option (ARKK)
American Airlines Group Note 6.500% 7/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mirati Therapeutics
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Splunk Note 1.125% 9/1 (Principal)
American Airls Put Option (AAL)
Ncl Corp Note 5.375% 8/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Brookdale Sr Living Unit 11/15/2025 (BKDT)

View all positions for CSS

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1